5-HT2C receptor modulation and the treatment of obesity

被引:36
作者
Bickerdike, MJ [1 ]
Vickers, SP [1 ]
Dourish, CT [1 ]
机构
[1] Cerebrus PLC, Wokingham RG41 5UA, England
关键词
D O I
10.1046/j.1463-1326.1999.00037.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:207 / 214
页数:8
相关论文
共 77 条
[1]  
AULAKH CS, 1995, NEUROPSYCHOPHARMACOL, V13, P1
[2]  
BENNETT N, 1995, HLTH SURVEY ENGLAND
[4]  
BLUNDELL JE, 1977, INT J OBESITY, V1, P15
[5]   RS-102221: A novel high affinity and selective, 5-HT2C receptor antagonist [J].
Bonhaus, DW ;
Weinhardt, KK ;
Taylor, M ;
Desouza, A ;
Mcneeley, PM ;
Szczepanski, K ;
Fontana, DJ ;
Trinh, J ;
Rocha, CL ;
Dawson, MW ;
Flippin, LA ;
Eglen, RM .
NEUROPHARMACOLOGY, 1997, 36 (4-5) :621-629
[6]   Obesity: a time bomb to be defused [J].
Bray, GA .
LANCET, 1998, 352 (9123) :160-161
[7]   (-)-M-CHLOROPHENYL-PIPERAZINE, A CENTRAL 5-HYDROXYTRYPTAMINE AGONIST, IS A METABOLITE OF TRAZODONE [J].
CACCIA, S ;
BALLABIO, M ;
SAMANIN, R ;
ZANINI, MG ;
GARATTINI, S .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1981, 33 (07) :477-478
[8]   A UNIQUE SEROTONIN RECEPTOR IN CHOROID-PLEXUS IS LINKED TO PHOSPHATIDYLINOSITOL TURNOVER [J].
CONN, PJ ;
SANDERSBUSH, E ;
HOFFMAN, BJ ;
HARTIG, PR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (11) :4086-4088
[9]  
CONN PJ, 1987, J PHARMACOL EXP THER, V242, P552
[10]   Valvular heart disease associated with fenfluramine-phentermine [J].
Connolly, HM ;
Crary, JL ;
McGoon, MD ;
Hensrud, DD ;
Edwards, BS ;
Edwards, WD ;
Schaff, HV .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (09) :581-588